Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
18.61
-0.16 (-0.85%)
At close: May 12, 2025, 4:00 PM
18.63
+0.02 (0.11%)
After-hours: May 12, 2025, 7:26 PM EDT
Rigel Pharmaceuticals Employees
As of December 31, 2024, Rigel Pharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,238,274
Profits / Employee
$226,695
Market Cap
332.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RIGL News
- 5 days ago - Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum - Seeking Alpha
- 5 days ago - Rigel Pharmaceuticals, Inc. (RIGL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 13 days ago - Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update - PRNewsWire
- 5 weeks ago - Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability - Seeking Alpha
- 5 weeks ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 6 weeks ago - Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation - PRNewsWire
- 2 months ago - Rigel Appoints Mark W. Frohlich, M.D. - PRNewsWire